Trademark: 86491548
Status Date
Thursday, February 16, 2023
Registration Number
5205321
Registration Date
Tuesday, May 16, 2017
Filing Date
Monday, December 29, 2014
Published for Opposition
Tuesday, December 29, 2015
5 biological enzyme for medical purposes; cDNA synthesizing compositions for medical purposes; cDNA synthesizing kits for medical purposes comprised primarily of regents, buffers, reverse transcriptase and oligo; nucleic acid fluorescence staining compositions for medical purposes; nucleic acid fluorescence staining kits for medical purposes comprised primarily of reagents, buffers, and dyes; DNA sequence analyzing compositions for medical purposes; DNA sequence analyzing kits for medical purpose comprised primarily of reagents, buffers and DNA polymerase; nucleic acid polymerase for medical purposes; nucleic acid amplifying compositions for medical purposes; nucleic acid amplifying kits for medical purposes comprised primarily of reagents, buffers, and nucleic acid polymerase; chemical reagent for medical purposes; restriction enzyme for medical purposes; polymerase chain reaction compositions for medical purposes; reverse transcription compositions for medical purposes
1 biological enzyme not for medical purposes; cDNA synthesizing compositions for research purpose; cDNA synthesizing kits for research purposes comprised primarily of reagents, buffers, reverse transcriptase and oligo; nucleic acid fluorescence staining compositions for research purpose; nucleic acid fluorescence staining kits for research purposes comprised primarily of reagents, buffers, and dyes; DNA sequence analyzing compositions for research purpose; DNA sequence analyzing kits for research purposes comprised primarily of reagents, buffers and DNA polymerase; nucleic acid polymerase for research purpose; nucleic acid amplifying compositions for research purpose; nucleic acid amplifying kits for research purposes comprised primarily of regents, buffers, and nucleic acid polymerase; chemical reagent for research purpose; restriction enzyme for research purpose; polymerase chain reaction compositions for research purpose; reverse transcription compositions for research purpose
Feb 16, 2023
Notice Of Acceptance Of Sec. 8 - E-Mailed
Feb 16, 2023
Registered - Sec. 8 (6-Yr) Accepted
Feb 15, 2023
Teas Response To Office Action-Post Reg Received
Jan 6, 2023
Post Registration Action Mailed - Sec. 8
Jan 6, 2023
Case Assigned To Post Registration Paralegal
Jul 12, 2022
Teas Section 8 Received
May 16, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 16, 2017
Registered-Principal Register
Apr 8, 2017
Notice Of Acceptance Of Statement Of Use E-Mailed
Apr 7, 2017
Allowed Principal Register - Sou Accepted
Oct 13, 2016
Notification Of Non-Final Action E-Mailed
Oct 13, 2016
Non-Final Action E-Mailed
Oct 13, 2016
Su - Non-Final Action - Written
Sep 22, 2016
Statement Of Use Processing Complete
Aug 15, 2016
Use Amendment Filed
Sep 7, 2016
Case Assigned To Intent To Use Paralegal
Aug 15, 2016
Teas Statement Of Use Received
Feb 23, 2016
Noa E-Mailed - Sou Required From Applicant
Dec 29, 2015
Official Gazette Publication Confirmation E-Mailed
Dec 29, 2015
Published For Opposition
Dec 9, 2015
Notification Of Notice Of Publication E-Mailed
Oct 13, 2015
Approved For Pub - Principal Register
Oct 10, 2015
Teas/Email Correspondence Entered
Oct 9, 2015
Correspondence Received In Law Office
Oct 9, 2015
Teas Response To Office Action Received
Apr 14, 2015
Notification Of Non-Final Action E-Mailed
Apr 14, 2015
Non-Final Action E-Mailed
Apr 14, 2015
Non-Final Action Written
Apr 7, 2015
Assigned To Examiner
Jan 9, 2015
Notice Of Pseudo Mark E-Mailed
Jan 8, 2015
New Application Office Supplied Data Entered
Jan 1, 2015
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
